Below is a list of grant and award recipients. You may narrow the list down by using the filters below. The list can be sorted by year, last name, and institution. The institution listed reflects the sponsoring institution at the time of grant or award.
Past Recipients Year First Name Last Name Degree Institutionsort descending Title Grant Amount ($) Subject Area
2003 Adela Dinu MD
2017 Stephen Mihalcik MD, PhD Massachusetts General Hospital A secondary analysis of PSA response in NRG Oncology/RTOG 9902: A phase III trial of adjuvant chemotherapy with androgen suppression and radiation for high-risk prostate cancer (CaP).
2019 Tessa Steenbruggen MD Netherlands Cancer Institute Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
2018 Simon Heidegger MD Technical University of Munich, Germany Melanoma cell-intrinsic RIG-I but not STING signaling is required for checkpoint inhibitor‑mediated anticancer immunity.
2017 Daniel Araujo MD A.C.  Camargo Cancer Center, Brazil
2005 Henrik Schmidt MD Aarhus University Hospital Evaluation of serum YKL-40 as a prognostic marker for overall survival in patients with metastatic malignant melanoma.
2008 Charles Adisa MBBS, FWACS, FICS Abia State University Teaching Hospital
2012 Mercy Isichei MBBS, MD Abubakar Tafawa Balewa University Teaching Hospital Bauchi
2004 Yasser Haba Addenbrooke's Hospital Favourable IGCCCG subgroups of stage II NSGCT patients may require less chemotherapy if TNM staging is included.
2006 Tejpal Gupta MD Advanced Centre for Treatment, Research and Education in Cancer
2019 Aleesha Adatia MBBS, MD Aga Khan Hospital Dar Es salaam
2014 John Weru MBBS (MBBCh or MBChB) Aga Khan University Hospital, Nairobi
2011 Sitna Mwanzi MBBS, MD, MS Aga Khan University Hospital, Nairobi
2012 Mateus Sahani MD Agir Ensemble pour le Driots de l'Homme (Act Together for Human Rights), France
2007 Seiji Ito Aichi Cancer Center Hospital Assessment of postoperative symptoms in gastric cancer patients after extended surgery: Results from a phase III trial comparing D2 and D2 plus para-aortic lymph node (PAN) dissection (D) (JCOG 9501).
2011 Jonair Labib MD, MSc Ain Shams University
2006 Mehmet Artac MD Akdeniz University
2016 Mohammed Abdulqader Suwaid MBChB, MD Al Anbar Oncology Center, Iraq
2017 Gerard Holder Alabama College of Osteopathic Medicine
2013 Albert Einstein Cancer Center
2016 Vineeth Sukrithan MD Albert Einstein Cancer Center Do risks with the use of erythropoeitin stimulating agents (ESAs) differ by tumor type? Implications concerning survival and thrombosis based on meta-analysis (MA).
2004 Anu Gaba MD Albert Einstein Cancer Center Cytosine-D Arabino-Furanoside (Ara-C) and CPT-11 inhibit cell proliferation in human colorectal cancer with microsatellite instability.
2016 Ali Zahalka BA, MSc Albert Einstein College of Medicine Sympathetic neural regulation of angiogenesis through Adrb2 in prostate cancer: A novel therapeutic target.
2018 Jose Galeas MD Albert Einstein College of Medicine Decreasing initiation of chemotherapy time in elective patients admitted to an inpatient hematology malignancy unit.
2004 Anusheel Munshi MD All India Institute of Medical Sciences
2011 Indranil Ghosh MD All India Institute of Medical Sciences
2014 Kameshwarachari Pushpalatha MBBS, MS All India Institute of Medical Sciences
2007 Sudip Sen MD, PhD All India Institute of Medical Sciences
2010 Haresh Kunhiparambath MBBS, MD, DNB All India Institute of Medical Sciences
2002 Atul Sharma MD All India Institute of Medical Sciences
2005 Navin Khattry MD All India Institute of Medical Sciences
2008 A.B. Rashid Mir All India Institute of Medical Sciences Prevalence, incidence, and clinical significance of two P-loop mutations (Y253H and E255N) in imatinib mesylate resistance CML patients.
2004 Manisha Bhutani MD All India Institute of Medical Sciences
2005 Tarun Durga MBBS, MD All India Institute of Medical Sciences Randomised study to access the efficacy of calcitonin in controlling pain in patients of metastatic bone lesions poorly responding to opioids.
2006 Ashutosh Pathak MBBS, PhD All India Institute of Medical Sciences
2012 Gaurav Prakash MBBS, MD All india institute of medical sciences
2016 Raja Pramanik MD All India Institute of Medical Sciences Metronomic therapy versus best supportive care in progressive pediatric solid malignancies: a double blind placebo controlled randomized study.
2019 Deepa Joseph MD All India Institute of Medical Sciences Rishikesh
2018 Sushma Bhatnagar MD All India Institute of Medical Sciences, India Palliative Care:Promoting Access & International Cancer Experience in India Collaborative (PC-PAICE India Collaborative) 20,000.00
2017 Raj Mohan MBBS All India Institute of Medical Sciences, India
2009 Dauren Adilbay MD Almaty Oncology Centre, Kazakhstan
2012 Altru Cancer Center
2017 Raya Saab MD American University of Beirut Medical Center, Lebanon Targeted education for general practitioners with development and application of a workflow for rapid second opinion, to promote early diagnosis and referral of children with suspected solid tumors 20,000.00
2017 Liliana Vasquez MD AMEROM, Peru ONCO-PEDS (Pediatric-Early-Diagnosis-System): A novel mobile application for early diagnosis and referral in childhood cancer 20,000.00
2007 Sani Malami MBBS Aminu Kano Teaching Hospital, Nigeria
2014 Lofty-john Anyanwu MBBS (MBBCh or MBChB) Aminu Kano Teaching Hospital, Nigeria
2016 Ali Alkan MD Ankara University School of Medicine, Turkey
2007 Jarrod Holmes MD Annadel Medical Group Clinical and immunologic effects of a HER2/neu (E75) peptide vaccine booster in previously vaccinated breast cancer patients.
2007 Jennifer Reed MD Anne Arundel Medical Center Assessing the utility of magnetic resonance imaging for surgical planning of DCIS breast cancer patients.
2016 Raphael Brandao Moreira MD Antonio Ermirio de Moraes Oncology Center, Brazil Differential side effects profile in mCRPC patients treated with abiraterone or enzalutamide: A meta-analysis of randomized controlled trials.